Provided by Tiger Trade Technology Pte. Ltd.

PAVmed

5.10
-0.0750-1.45%
Pre-market: 4.88-0.2200-4.31%05:00 EDT
Volume:17.50K
Turnover:89.30K
Market Cap:35.66M
PE:-0.31
High:5.24
Open:5.03
Low:5.01
Close:5.18
52wk High:28.44
52wk Low:3.85
Shares:6.99M
Float Shares:4.42M
Volume Ratio:1.14
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.4698
EPS(LYR):-5.6300
ROE:-64.78%
ROA:-39.69%
PB:1.14
PE(LYR):-0.91

Loading ...

PAVmed schedules quarterly business update call, to report Q1 results

Reuters
·
May 01

Lucid Diagnostics to host business update call, report first-quarter results

Reuters
·
Apr 30

Lucid Diagnostics closes USD 18 million follow-on offering of common stock

Reuters
·
Apr 24

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

THOMSON REUTERS
·
Apr 24

Lucid Diagnostics prices $18 million stock offering at $1 per share

Reuters
·
Apr 23

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

THOMSON REUTERS
·
Apr 23

BRIEF-PAVmed Inc - Files Prospectus For Potential Offer And Sale Of 9.23 Million Common Shares By Selling Stockholders - SEC Filing

Reuters
·
Apr 21

PAVmed files to sell 9.23M shares of common stock for holders

TIPRANKS
·
Apr 21

PAVmed Inc - Files Prospectus for Potential Offer and Sale of 9.23 Mln Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Apr 21

Lucid Diagnostics announces annual shareholder meeting

Reuters
·
Apr 21

Lucid Diagnostics files Form 3 for Chief Medical Officer Victoria Tou-ho Lee

Reuters
·
Apr 14

PAVmed files Form 3 for Chief Medical Officer Victoria Tou-ho Lee

Reuters
·
Apr 14

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Apr 10

PAVmed unit Lucid Diagnostics to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 09

PAVmed files Form 3 initial beneficial ownership statement for Tasso Partners LLC

Reuters
·
Apr 07

Press Release: PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Dow Jones
·
Apr 02

PAVmed price target lowered to $16 from $60 at Maxim

TIPRANKS
·
Mar 31

PAVmed Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 30

PAVmed Reports 2025 Results, Strengthens Balance Sheet

TIPRANKS
·
Mar 30

PAVmed FY25 net loss narrows to $3.8 million; revenue falls to $0.1 million

Reuters
·
Mar 30